{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:00Z","timestamp":1740106920825,"version":"3.37.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre national de la recherche scientifique","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association de Lutte Contre le Sida","award":["FASP2016","FASP2016","FASP2016","FASP2016","FASP2016","FASP2016"],"award-info":[{"award-number":["FASP2016","FASP2016","FASP2016","FASP2016","FASP2016","FASP2016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00203-023-03574-0","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T07:02:41Z","timestamp":1683529361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of the first-line antiretroviral therapy on soluble markers of inflammation in cohort of human immunodeficiency virus type 1 in Moroccan patients: a prospective study"],"prefix":"10.1007","volume":"205","author":[{"given":"Asmaa","family":"Haddaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahd","family":"Ouladlahsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Lkhider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajaa","family":"Bensghir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa","family":"Jebbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soufiane","family":"Hilmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam","family":"Abbadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Sodqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latifa","family":"Marih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal Marhoum","family":"El Filali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayeh","family":"Ezzikouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"3574_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S2055-6640(20)30688-9","volume":"2","author":"J Ananworanich","year":"2016","unstructured":"Ananworanich J, Sacdalan CP, Pinyakorn S et al (2016) Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection. J Virus Erad 2:43\u201348","journal-title":"J Virus Erad"},{"key":"3574_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/QAI.0b013e3181f7f61a","volume":"56","author":"JV Baker","year":"2011","unstructured":"Baker JV, Neuhaus J, Duprez D et al (2011) Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr 56:36\u201343. https:\/\/doi.org\/10.1097\/QAI.0b013e3181f7f61a","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3574_CR3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s13063-020-04678-4","volume":"21","author":"JV Baker","year":"2017","unstructured":"Baker JV, Sharma S, Grund B et al (2017) Systemic inflammation, coagulation, and clinical risk in the START trial. Open Forum Infect Dis 21:770. https:\/\/doi.org\/10.1186\/s13063-020-04678-4","journal-title":"Open Forum Infect Dis"},{"key":"3574_CR4","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1172\/JCI26032","volume":"115","author":"A-S Beignon","year":"2005","unstructured":"Beignon A-S (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor- viral RNA interactions. J Clin Investig 115:3265\u20133275. https:\/\/doi.org\/10.1172\/JCI26032","journal-title":"J Clin Investig"},{"key":"3574_CR5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/QAD.0b013e32835f6b0c","volume":"27","author":"\u00c1H Borges","year":"2013","unstructured":"Borges \u00c1H, Silverberg MJ, Wentworth D et al (2013) Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS 27:1433\u20131441. https:\/\/doi.org\/10.1097\/QAD.0b013e32835f6b0c","journal-title":"AIDS"},{"key":"3574_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/infdis\/jiv123","volume":"212","author":"\u00c1H Borges","year":"2015","unstructured":"Borges \u00c1H, O\u2019Connor JL, Phillips AN et al (2015) Factors associated with plasma IL-6 levels during HIV infection. J Infect Dis 212:585\u2013595. https:\/\/doi.org\/10.1093\/infdis\/jiv123","journal-title":"J Infect Dis"},{"key":"3574_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/infdis\/jiw173","volume":"214","author":"\u00c1H Borges","year":"2016","unstructured":"Borges \u00c1H, O\u2019Connor JL, Phillips AN et al (2016) Interleukin 6 is a stronger predictor of clinical events than high-sensitivity C-reactive protein or D-Dimer during HIV infection. J Infect Dis 214:408\u2013416. https:\/\/doi.org\/10.1093\/infdis\/jiw173","journal-title":"J Infect Dis"},{"key":"3574_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley JM, Schacker TW, Ruff LE et al (2004) CD4+ T Cell Depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749\u2013759. https:\/\/doi.org\/10.1084\/jem.20040874","journal-title":"J Exp Med"},{"key":"3574_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW et al (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12:1365\u20131371. https:\/\/doi.org\/10.1038\/nm1511","journal-title":"Nat Med"},{"key":"3574_CR10","doi-asserted-by":"publisher","first-page":"ofaa564","DOI":"10.1093\/ofid\/ofaa564","volume":"8","author":"JR Castillo-Mancilla","year":"2020","unstructured":"Castillo-Mancilla JR, Brown TT, Palella FJ Jr et al (2020) Partial normalization of biomarkers of inflammation and immune activation among virally suppressed men with HIV infection and high ART adherence. Open Forum Infect Dis 8:ofaa564. https:\/\/doi.org\/10.1093\/ofid\/ofaa564","journal-title":"Open Forum Infect Dis"},{"key":"3574_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/infdis\/jir208","volume":"204","author":"TW Chun","year":"2011","unstructured":"Chun TW, Murray D, Justement JS et al (2011) Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. J Infect Dis 204:135\u2013138. https:\/\/doi.org\/10.1093\/infdis\/jir208","journal-title":"J Infect Dis"},{"key":"3574_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12977-018-0458-6","volume":"15","author":"HHS de Paula","year":"2018","unstructured":"de Paula HHS, Ferreira ACG, Caetano DG et al (2018) Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection. Retrovirology 15:76. https:\/\/doi.org\/10.1186\/s12977-018-0458-6","journal-title":"Retrovirology"},{"key":"3574_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","volume":"280","author":"R Detels","year":"1998","unstructured":"Detels R, Mu\u00f1oz A, McFarlane G et al (1998) Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA 280:1497. https:\/\/doi.org\/10.1001\/jama.280.17.1497","journal-title":"JAMA"},{"key":"3574_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/bmj.315.7117.1194","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Hirschel B, Francioli P et al (1997) Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 315:1194\u20131199. https:\/\/doi.org\/10.1136\/bmj.315.7117.1194","journal-title":"BMJ"},{"key":"3574_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12981-016-0111-1","volume":"13","author":"SP Eholi\u00e9","year":"2016","unstructured":"Eholi\u00e9 SP, Badje A, Kouame GM et al (2016) Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question. AIDS Res Ther 13:27. https:\/\/doi.org\/10.1186\/s12981-016-0111-1","journal-title":"AIDS Res Ther"},{"key":"3574_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12879-017-2676-2","volume":"17","author":"F Falasca","year":"2017","unstructured":"Falasca F, Di Carlo D, De Vito C et al (2017) Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infect Dis 17:581. https:\/\/doi.org\/10.1186\/s12879-017-2676-2","journal-title":"BMC Infect Dis"},{"key":"3574_CR18","doi-asserted-by":"publisher","first-page":"e1006285","DOI":"10.1371\/journal.ppat.1006285","volume":"13","author":"RT Gandhi","year":"2017","unstructured":"Gandhi RT, McMahon DK, Bosch RJ et al (2017) Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. PLoS Pathog 13:e1006285. https:\/\/doi.org\/10.1371\/journal.ppat.1006285","journal-title":"PLoS Pathog"},{"key":"3574_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1086\/649430","volume":"201","author":"A Ganesan","year":"2010","unstructured":"Ganesan A, Chattopadhyay PK, Brodie TM et al (2010) Immunologic and virologic events in early HIV infection predict subsequent rate of progression. J Infect Dis 201:272\u2013284. https:\/\/doi.org\/10.1086\/649430","journal-title":"J Infect Dis"},{"key":"3574_CR20","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1093\/infdis\/jiw217","volume":"214","author":"S Gianella","year":"2016","unstructured":"Gianella S, Letendre S (2016) Cytomegalovirus and HIV: a dangerous Pas de Deux. J Infect Dis 214:S67\u2013S74. https:\/\/doi.org\/10.1093\/infdis\/jiw217","journal-title":"J Infect Dis"},{"key":"3574_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1086\/314660","volume":"179","author":"JV Giorgi","year":"1999","unstructured":"Giorgi JV, Hultin LE, McKeating JA et al (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179:859\u2013870. https:\/\/doi.org\/10.1086\/314660","journal-title":"J Infect Dis"},{"key":"3574_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1097\/QAD.0000000000000675","volume":"29","author":"E Hamlyn","year":"2015","unstructured":"Hamlyn E, St\u00f6hr W, Cooper DA et al (2015) The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels. AIDS 29:1355\u20131361. https:\/\/doi.org\/10.1097\/QAD.0000000000000675","journal-title":"AIDS"},{"key":"3574_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40265-016-0546-7","volume":"76","author":"DC Hsu","year":"2016","unstructured":"Hsu DC, Sereti I (2016) Serious non-AIDS events: therapeutic targets of immune activation and chronic inflammation in HIV infection. Drugs 76:533\u2013549. https:\/\/doi.org\/10.1007\/s40265-016-0546-7","journal-title":"Drugs"},{"key":"3574_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/cid\/ciw697","volume":"64","author":"PW Hunt","year":"2017","unstructured":"Hunt PW (2017) Very early ART and persistent inflammation in treated HIV. Clin Infect Dis 64:132\u2013133. https:\/\/doi.org\/10.1093\/cid\/ciw697","journal-title":"Clin Infect Dis"},{"key":"3574_CR25","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1086\/374786","volume":"187","author":"PW Hunt","year":"2003","unstructured":"Hunt PW, Martin JN, Sinclair E et al (2003) T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus\u2013infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187:1534\u20131543. https:\/\/doi.org\/10.1086\/374786","journal-title":"J Infect Dis"},{"key":"3574_CR26","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1093\/infdis\/jiw275","volume":"214","author":"PW Hunt","year":"2016","unstructured":"Hunt PW, Lee SA, Siedner MJ (2016) Immunologic biomarkers, morbidity, and mortality in treated HIV infection. J Infect Dis 214:S44\u2013S50. https:\/\/doi.org\/10.1093\/infdis\/jiw275","journal-title":"J Infect Dis"},{"key":"3574_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"INSIGHT START Study Group, Lundgren JD, Babiker AG et al (2015) Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 373:795\u2013807. https:\/\/doi.org\/10.1056\/NEJMoa1506816","journal-title":"N Engl J Med"},{"key":"3574_CR28","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/infdis\/jit311","volume":"208","author":"V Jain","year":"2013","unstructured":"Jain V, Hartogensis W, Bacchetti P et al (2013) Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 208:1202\u20131211. https:\/\/doi.org\/10.1093\/infdis\/jit311","journal-title":"J Infect Dis"},{"key":"3574_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/COH.0b013e328335c0c1","volume":"5","author":"B Kanwar","year":"2010","unstructured":"Kanwar B, Favre D, McCune JM (2010) Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIV AIDS 5:151\u2013157. https:\/\/doi.org\/10.1097\/COH.0b013e328335c0c1","journal-title":"Curr Opin HIV AIDS"},{"key":"3574_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12879-022-07450-y","volume":"22","author":"AD Knudsen","year":"2022","unstructured":"Knudsen AD, Bouazzi R, Afzal S et al (2022) Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls. BMC Infect Dis 22:451. https:\/\/doi.org\/10.1186\/s12879-022-07450-y","journal-title":"BMC Infect Dis"},{"key":"3574_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/infdis\/jiv145","volume":"212","author":"E Krastinova","year":"2015","unstructured":"Krastinova E, Lecuroux C, Leroy C et al (2015) High soluble CD14 levels at primary HIV-1 infection predict more rapid disease progression. J Infect Dis 212:909\u2013913. https:\/\/doi.org\/10.1093\/infdis\/jiv145","journal-title":"J Infect Dis"},{"key":"3574_CR32","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","volume":"5","author":"LH Kuller","year":"2008","unstructured":"Kuller LH, Tracy R, Belloso W et al (2008) Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 5:e203. https:\/\/doi.org\/10.1371\/journal.pmed.0050203","journal-title":"PLoS Med"},{"key":"3574_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/484378","volume":"2013","author":"A Kumar","year":"2013","unstructured":"Kumar A, Abbas W, Herbein G (2013) TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy? Mediat Inflamm 2013:1\u201313. https:\/\/doi.org\/10.1155\/2013\/484378","journal-title":"Mediat Inflamm"},{"key":"3574_CR34","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/archinternmed.2010.197","volume":"170","author":"S Lang","year":"2010","unstructured":"Lang S, Mary-Krause M, Cotte L et al (2010) Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus\u2013infected patients. Arch Intern Med 170:1228\u20131238. https:\/\/doi.org\/10.1001\/archinternmed.2010.197","journal-title":"Arch Intern Med"},{"key":"3574_CR35","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1086\/379900","volume":"188","author":"HM Lederman","year":"2003","unstructured":"Lederman HM, Williams PL, Wu JW et al (2003) Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus\u2013infected patients with severe CD4+ cell depletion. J Infect Dis 188:1794\u20131803. https:\/\/doi.org\/10.1086\/379900","journal-title":"J Infect Dis"},{"key":"3574_CR36","doi-asserted-by":"publisher","first-page":"e24243","DOI":"10.1371\/journal.pone.0024243","volume":"7","author":"L Ledwaba","year":"2012","unstructured":"Ledwaba L, Tavel JA, Khabo P et al (2012) Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease. PLoS ONE 7:e24243. https:\/\/doi.org\/10.1371\/journal.pone.0024243","journal-title":"PLoS ONE"},{"key":"3574_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/QAI.0b013e318134257a","volume":"46","author":"C Lewden","year":"2007","unstructured":"Lewden C, Chene G, Morlat P et al (2007) HIV-infected adults with a CD4 cell count greater than 500 Cells\/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 46:72\u201377. https:\/\/doi.org\/10.1097\/QAI.0b013e318134257a","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3574_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/7316456","volume":"2021","author":"T Lv","year":"2021","unstructured":"Lv T, Cao W, Li T (2021) HIV-related immune activation and inflammation: current understanding and strategies. J Immunol Res 2021:1\u201313. https:\/\/doi.org\/10.1155\/2021\/7316456","journal-title":"J Immunol Res"},{"key":"3574_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/01.qai.0000437171.00504.41","volume":"65","author":"GA McComsey","year":"2014","unstructured":"McComsey GA, Kitch D, Sax PE et al (2014) Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202.16. J Acquir Immune Defic Syndr 65:167\u2013174. https:\/\/doi.org\/10.1097\/01.qai.0000437171.00504.41","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3574_CR40","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1089\/aid.2012.0309","volume":"29","author":"B McDonald","year":"2013","unstructured":"McDonald B, Moyo S, Gabaitiri L et al (2013) Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. AIDS Res Hum Retrovir 29:993\u2013999. https:\/\/doi.org\/10.1089\/aid.2012.0309","journal-title":"AIDS Res Hum Retrovir"},{"key":"3574_CR41","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/infdis\/jit025","volume":"207","author":"G M\u00e9ndez-Lagares","year":"2013","unstructured":"M\u00e9ndez-Lagares G, Romero-S\u00e1nchez MC, Ruiz-Mateos E et al (2013) Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14. J Infect Dis 207:1221\u20131225. https:\/\/doi.org\/10.1093\/infdis\/jit025","journal-title":"J Infect Dis"},{"key":"3574_CR42","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1086\/652749","volume":"201","author":"J Neuhaus","year":"2010","unstructured":"Neuhaus J, Jacobs DR Jr, Baker JV et al (2010) Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201:1788\u20131795. https:\/\/doi.org\/10.1086\/652749","journal-title":"J Infect Dis"},{"key":"3574_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/v9040064","volume":"9","author":"S Pasquereau","year":"2017","unstructured":"Pasquereau S, Kumar A, Herbein G (2017) Targeting TNF and TNF receptor pathway in HIV-1 infection: from immune activation to viral reservoirs. Viruses 9:64. https:\/\/doi.org\/10.3390\/v9040064","journal-title":"Viruses"},{"key":"3574_CR44","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/QAD.0b013e32835ecb8b","volume":"27","author":"R Rajasuriar","year":"2013","unstructured":"Rajasuriar R, Khoury G, Kamarulzaman A et al (2013) Persistent immune activation in chronic HIV infection: do any interventions work? AIDS 27:1199\u20131208. https:\/\/doi.org\/10.1097\/QAD.0b013e32835ecb8b","journal-title":"AIDS"},{"key":"3574_CR45","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1073\/pnas.0901983106","volume":"106","author":"AD Redd","year":"2009","unstructured":"Redd AD, Dabitao D, Bream JH et al (2009) Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A 106:6718\u20136723. https:\/\/doi.org\/10.1073\/pnas.0901983106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3574_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/QAD.0b013e32834273ad","volume":"25","author":"DL Regidor","year":"2011","unstructured":"Regidor DL, Detels R, Breen EC et al (2011) Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS 25:303\u2013314. https:\/\/doi.org\/10.1097\/QAD.0b013e32834273ad","journal-title":"AIDS"},{"key":"3574_CR47","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1086\/605447","volume":"200","author":"AJ Rodger","year":"2009","unstructured":"Rodger AJ, Fox Z, Lundgren JD et al (2009) Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 200:973\u2013983. https:\/\/doi.org\/10.1086\/605447","journal-title":"J Infect Dis"},{"key":"3574_CR48","doi-asserted-by":"publisher","first-page":"e1004543","DOI":"10.1371\/journal.ppat.1004543","volume":"10","author":"A Schuetz","year":"2014","unstructured":"Schuetz A, Deleage C, Sereti I et al (2014) Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog 10:e1004543. https:\/\/doi.org\/10.1371\/journal.ppat.1004543","journal-title":"PLoS Pathog"},{"key":"3574_CR49","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/infdis\/jiv450","volume":"213","author":"MJ Siedner","year":"2016","unstructured":"Siedner MJ, Kim JH, Nakku RS et al (2016) Persistent immune activation and carotid atherosclerosis in HIV-infected ugandans receiving antiretroviral therapy. J Infect Dis 213:370\u2013378. https:\/\/doi.org\/10.1093\/infdis\/jiv450","journal-title":"J Infect Dis"},{"key":"3574_CR50","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1086\/375351","volume":"187","author":"A Solomon","year":"2003","unstructured":"Solomon A, Cameron PU, Bailey M et al (2003) Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicity. J Infect Dis 187:1915\u20131923. https:\/\/doi.org\/10.1086\/375351","journal-title":"J Infect Dis"},{"key":"3574_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/QAD.0000000000000511","volume":"29","author":"M Somsouk","year":"2015","unstructured":"Somsouk M, Estes JD, Deleage C et al (2015) Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS 29:43\u201351. https:\/\/doi.org\/10.1097\/QAD.0000000000000511","journal-title":"AIDS"},{"key":"3574_CR52","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2018.00212","volume":"9","author":"A Song","year":"2018","unstructured":"Song A, Liu X, Huang X, Meyers K et al (2018) From CD4-based initiation to treating all HIV-infected adults immediately: an evidence-based meta-analysis. Front Immunol 9:212. https:\/\/doi.org\/10.3389\/fimmu.2018.00212","journal-title":"Front Immunol"},{"key":"3574_CR53","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1128\/JVI.01844-08","volume":"83","author":"AR Stacey","year":"2009","unstructured":"Stacey AR, Norris PJ, Qin L et al (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83:3719\u20133733. https:\/\/doi.org\/10.1128\/JVI.01844-08","journal-title":"J Virol"},{"key":"3574_CR54","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/gerona\/gls178","volume":"67","author":"JR Stehle Jr","year":"2012","unstructured":"Stehle JR Jr, Leng X, Kitzman DW et al (2012) Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. J Gerontol A Biol Sci Med Sci 67:1212\u20131218. https:\/\/doi.org\/10.1093\/gerona\/gls178","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3574_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-94-024-0921-5_4","volume":"941","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Narazaki M, Masuda K et al (2016) Regulation of IL-6 in immunity and diseases. Adv Exp Med Biol 941:79\u201388. https:\/\/doi.org\/10.1007\/978-94-024-0921-5_4","journal-title":"Adv Exp Med Biol"},{"key":"3574_CR56","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/infdis\/jiu206","volume":"210","author":"SA Vaidya","year":"2014","unstructured":"Vaidya SA, Korner C, Sirignano MN et al (2014) Tumor necrosis factor \u03b1 is associated with viral control and early disease progression in patients with HIV type 1 infection. J Infect Dis 210:1042\u20131046. https:\/\/doi.org\/10.1093\/infdis\/jiu206","journal-title":"J Infect Dis"},{"key":"3574_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1126\/science.280.5362.427","volume":"280","author":"RS Veazey","year":"1998","unstructured":"Veazey RS, DeMaria M, Chalifoux LV et al (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280:427\u2013431. https:\/\/doi.org\/10.1126\/science.280.5362.427","journal-title":"Science"},{"key":"3574_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","volume":"29","author":"NI Wada","year":"2015","unstructured":"Wada NI, Jacobson LP, Margolick JB et al (2015) The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS 29:463\u2013471. https:\/\/doi.org\/10.1097\/QAD.0000000000000545","journal-title":"AIDS"},{"key":"3574_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/hiv.12310","volume":"2","author":"M Younas","year":"2016","unstructured":"Younas M, Psomas C, Reynes J et al (2016) Immune activation in the course of HIV-1 infection: causes, phenotypes and persistence under therapy. HIV Med 2:89\u2013105. https:\/\/doi.org\/10.1111\/hiv.12310","journal-title":"HIV Med"},{"key":"3574_CR60","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3389\/fimmu.2019.02185","volume":"10","author":"M Younas","year":"2019","unstructured":"Younas M, Psomas C, Reynes C et al (2019) Microbial translocation is linked to a specific immune activation profile in HIV-1-infected adults with suppressed viremia. Front Immunol 10:2185. https:\/\/doi.org\/10.3389\/fimmu.2019.02185","journal-title":"Front Immunol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-023-03574-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T04:02:38Z","timestamp":1686283358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-023-03574-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3574"],"URL":"https:\/\/doi.org\/10.1007\/s00203-023-03574-0","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"type":"print","value":"0302-8933"},{"type":"electronic","value":"1432-072X"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee of the Faculty of Medicine of Rabat (01\/03\/2018, Number 24\/18).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent to participate was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"223"}}